Sign in to view content

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K. Maturi, MD

Video
Published 2021

Related

Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more
Jayanth Sridhar, MD
Daniel L Chao, MD, PhD
Ferhina S Ali, MD, MPH
Member Podcasts
2020
Proliferative Diabetic Retinopathy with Macular Isquemia by OCT Angiography
JORGE SOBERANES
Retina Image Bank: Images of the Week
2022
Intravitreal Methotrexate Reduces Reoperation Rate and Improves Vision After Vitrectomy for Retinal Detachment, Trauma, and Proliferative Diabetic Retinopathy
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2022

Category: Diabetic Retinopathy

See more